for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Japan's Takeda takeover bid causes investor headache

Posted

Takeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up